This briefing explains what NHSmail multi-factor authentication (MFA) is and how to use it. Briefing 016.24 nhsmail and multi factor authentication Last reviewed: 2024 Last updated: 2024 Further details about MFA can be found at: cpe.org.uk/mfa The post Briefing 016/24: NHSmail and multi-factor authentication appeared first on Community Pharmacy England.
Early in 2024, the Committee considered the challenges ahead looking at what the strategy should be for both the community pharmacy sector and Community Pharmacy England. This briefing summarises our strategy and workplan for the coming year. Briefing 016/24: Community Pharmacy England Strategy The post Briefing 016/24: Community Pharmacy England Strategy appeared first on Community
Community Pharmacy England is entirely funded by pharmacy owners via the levy charged to LPCs and all of the funding is devoted to fulfilling the functions outlined in our Strategy and Workplan, largely through direct staffing costs or externally commissioned professional advice and services. We deliver our work via core functions/teams: funding, NHS services, legal
This report provides a final update to LPCs and pharmacy owners about the work undertaken to Transform Pharmacy Representation following the mandate from contractors to deliver the Review Steering Group (RSG) recommendations. All of the workstreams have been completed by July 2024 as originally set out. The report provides: An update on the overarching TAPR
Community Pharmacy England met in Birmingham for a full Committee Meeting on 26th and 27th June 2024. Committee discussions focused on the urgent challenges facing all community pharmacy owners. The Committee also re-evaluated Community Pharmacy England’s immediate priorities for when the new Government is formed, continuing to deliver the strategy to build a better future
As part of Community Pharmacy England’s commitment to working more closely with pharmacy owners – listening to them better, as well as engaging more regularly via events and other channels – we sought input from the sector ahead of our June 2024 Committee Meeting. Between 3rd and 18th June, our June Committee opinion poll was
This briefing provides some information on the change in regulations and some FAQs. Briefing: 011/24: New restrictions on the prescriptions and supply of puberty blockers The post Briefing 011/24: New restrictions on the prescriptions and supply of puberty blockers appeared first on Community Pharmacy England.
This Briefing provides information for pharmacy teams on the Pharmacy First service which started on 31st January 2024. Briefing 010/24: Briefing for pharmacy teams – the Pharmacy First service The post Briefing 010/24: Briefing for pharmacy teams – the Pharmacy First service appeared first on Community Pharmacy England.
This Community Pharmacy England Briefing provides information for Local Medical Committees and general practices on the Pharmacy First service. Briefing 009/24: Briefing for Local Medical Committees and general practices on the Pharmacy First service The post Briefing 009/24: Briefing for Local Medical Committees and general practices on the Pharmacy First service appeared first on Community
This briefing describes how community pharmacy teams can take part in Community Pharmacy England’s Pharmacy Advice Audit to capture information about the increasing number of people relying on pharmacies. It sets out the criteria for inclusion, what data needs to be recorded and addresses key questions. Briefing 008/24: Pharmacy Advice Audit 2024 – Team Guide
Community Pharmacy England met in London for a full Committee Meeting on 17th and 18th April 2024. The Committee were joined by LPC leaders from the South East region for part of the meeting. The LPC attendees had the chance to network with Committee Members, observe subcommittee meetings and provide feedback from their local pharmacy
From April 2024, a transition to new arrangements for the setting of Drug Tariff Category A reimbursement prices will be implemented by the Department of Health and Social Care (DHSC). The changes to Category A, imposed by DHSC, form part of a series of community pharmacy drug reimbursement reforms following a public consultation in 2019.
